AstraZeneca PLC ADR Outperforms Competitors On Strong Trading Day

Dow Jones
2025.11.13 22:21
portai
I'm PortAI, I can summarize articles.

AstraZeneca PLC ADR rose 1.06% to $88.61, outperforming competitors in a grim trading session where NASDAQ fell 2.29% and Dow Jones fell 1.65%. It closed 0.79% below its 52-week high. Competitors Eli Lilly, Biogen, and Johnson & Johnson also saw gains. Trading volume was below average. Data compiled on November 13, 2025.

This article was automatically generated by MarketWatch using technology from Automated Insights. The AstraZeneca PLC ADR (AZN) rose 1.06% to $88.61 Thursday, on what proved to be an all-around grim trading session for the stock market, with the NASDAQ Composite Index falling 2.29% to 22,870.36 and Dow Jones Industrial Average falling 1.65% to 47,457.22. AstraZeneca PLC ADR closed 0.79% below its 52-week high of $89.32, which the company achieved on November 11th. The ADR demonstrated a mixed performance when compared to some of its competitors Thursday, as Eli Lilly & Co. (LLY) rose 0.50% to $1,022.87, Biogen Inc. (BIIB) rose 2.01% to $164.73, and Johnson & Johnson (JNJ) rose 0.44% to $195.25. Trading volume (4.5 M) remained 494,758 below its 50-day average volume of 5.0 M. Data source: Dow Jones Market Data, FactSet. Data compiled November 13, 2025. This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal. (END) Dow Jones Newswires 11-13-25 1721ET
Source: Dow Jones The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.